Entera Bio
ENTX
10 hedge funds and large institutions have $2.44M invested in Entera Bio in 2023 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 3 increasing their positions, 1 reducing their positions, and 4 closing their positions.
200% more repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 1
30% more capital invested
Capital invested by funds: $1.87M → $2.44M (+$567K)
5.15% more ownership
Funds ownership: 8.95% → 14.11% (+5.2%)
17% less funds holding
Funds holding: 12 → 10 (-2)
50% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 4
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
KCM
Knoll Capital Management
Miami,
Florida
|
+$953K |
| 2 |
TSS
Two Sigma Securities
New York
|
+$47.4K |
| 3 |
Renaissance Technologies
New York
|
+$23.2K |
| 4 |
Morgan Stanley
New York
|
+$682 |
| 5 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
+$136 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
-$10.5K |
| 2 |
Millennium Management
New York
|
-$871 |
| 3 |
UBS Group
Zurich,
Switzerland
|
-$445 |
| 4 |
SCA
Stonebridge Capital Advisors
St Paul,
Minnesota
|
-$145 |
| 5 |
Simplex Trading
Chicago,
Illinois
|
-$59 |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
KCM
1
Knoll Capital Management
Miami,
Florida
| $2.33M | +$953K | +1,397,604 | +56% |
|
|
TSS
2
Two Sigma Securities
New York
| $41.7K | +$47.4K | +69,441 | New |
|
|
3
Renaissance Technologies
New York
| $34K | +$23.2K | +34,000 | +145% |
|
4
Geode Capital Management
Boston,
Massachusetts
| $10.6K | – | – | – |
|
5
PNC Financial Services Group
Pittsburgh,
Pennsylvania
| $7.8K | – | – | – |
|
6
HighTower Advisors
Chicago,
Illinois
| $7K | – | – | – |
|
|
7
Millennium Management
New York
| $6.06K | -$871 | -1,277 | -11% |
|
|
8
Morgan Stanley
New York
| $1.2K | +$682 | +1,000 | +100% |
|
9
Group One Trading
Chicago,
Illinois
| $207 | – | – | – |
|
|
10
Citadel Advisors
Miami,
Florida
| – | -$10.5K | -15,368 | Closed |
|
|
11
UBS Group
Zurich,
Switzerland
| – | -$445 | -614 | Closed |
|
|
SCA
12
Stonebridge Capital Advisors
St Paul,
Minnesota
| – | -$145 | -200 | Closed |
|
|
13
Simplex Trading
Chicago,
Illinois
| – | -$59 | -86 | Closed |
|
|
14
Royal Bank of Canada
Toronto,
Ontario, Canada
| – | +$136 | +200 | New |
|
ENTX Hedge Fund Activity: Q4 2023 in Review
10 of the 6,859 institutional investors tracked by Wall St. Rank reported a position in Entera Bio (ENTX) for Q4 2023, worth a combined $2.44M — up 30% from $1.87M a quarter earlier.
Sellers outnumbered buyers: 4 funds closed out of ENTX and 2 opened new positions — a net loss of 2 holders — while 1 trimmed existing stakes and 3 added.
The largest buyer was Knoll Capital Management, adding an estimated $953K. The largest seller was Citadel Advisors, exiting entirely with an estimated $10.5K sold.
- 10 institutional investors held Entera Bio (ENTX) as of Q4 2023, down from 12 in Q3 2023.
- Funds reported $2.44M of Entera Bio stock for Q4 2023, up 30% quarter-over-quarter.
- 2 funds opened new Entera Bio positions in Q4 2023 and 4 closed out, a net change of -2 holders.
- The largest Entera Bio buyer in Q4 2023 was Knoll Capital Management, an estimated $953K added.
- The largest Entera Bio seller in Q4 2023 was Citadel Advisors, an estimated $10.5K sold.
Based on aggregated 13F filings for Q4 2023.